Dark Circle Reduction Activity of Earthsukh Under-eye Serum

A Clinical Study to Evaluate the Dark Circle Reduction Activity of Earthsukh Under-eye Serum on Healthy Human Subjects - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071138

Enrollment

Registered

2024-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Under Eye serum: Dose: Apply half a pump on the area below the eye & across the eye area below & above the eye lid with a finger in an outward manner. Duration- Two times a day Route of

Eligibility

Inclusion criteria

Inclusion criteria: 1. Voluntary man or women between 30 and 70 years with 1:2. 2. Having apparently healthy skin on test area and Must have dark under eye circles and puffiness 4. For whom the investigator considers that the compliance will be correct. 5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. 6. Having signed a Consent Form. 7. Willingness to avoid intense UV exposure on test site (sun or artificial UV) during the course of the study. 8. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study. 9. Should be able to read and write (in English, Hindi or local language). 10. Having valid proof of identity and age.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2.Scars, excessive terminal hair or tattoo on the studied area 3.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 4.No Anti-ageing or skin tone products to be used in parallel 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Genetic Dark Circles cases to be excluded 8.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

Design outcomes

Primary

Measure	Time frame
Change in Skin Hydration, Melanin content, Lightness, VAS Scale for puffinessTimepoint: Day 0, Day 28, and Day 56	—

Secondary

Measure	Time frame
To assess the safety and tolerabilityTimepoint: 0-56 days	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results